JPRN-UMIN000004167Completed未知
Efficacy of aprepitant on postoperative nausea and vomiting: Assesement with patient-controlled prevention of nause and vomiting (PCPNV). - Aprepitant inhibits PONV
Tohoku University Graduate School of Dentistry0 sites40 target enrollmentStarted: September 7, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18years-old to 40years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with pregnancy, having vomiting with 24 h before surgery in any etiology, allergy to any medications to be used prtioperatively, hepatic and renal disfunction. Patients taking medications known to induce or inhibit cytochrome P-450 3A4.
Investigators
Similar Trials
Terminated
Phase 4
Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective HysterectomyPostoperative Nausea and VomitingNCT00888329Mayo Clinic256
Active, not recruiting
Phase 4
The Effect of Aprepitant Reducing Postoperative Nausea and VomitingNausea and Vomiting, PostoperativeObesityNCT05772676Hospital General Tlahuac400
Completed
Not Applicable
Postoperative analgesia, and postoperative nausea and vomitingJPRN-UMIN000022672Tokushima University60
Not yet recruiting
Not Applicable
Antiemetic prophylaxis from postoperative nausea and vomiting in orthognathic surgery: a randomized, double-blind comparison of granisetrojaw deformityJPRN-UMIN000046776Kyoto jaw deformity center, Rakuwakai Otowa Hospital244
Completed
Not Applicable
Preventing postoperative nausea and vomiting - a quality improvement projectPostoperative nausea and vomitingSurgeryISRCTN45566845niversity Medical Center Groningen7,900